Study: L-Grb2 Has Therapeutic Efficacy in Preclinical Models of Ovarian and Uterine Cancer
July 23, 2020 3:00 pmThe cover for issue 29 of Oncotarget features, “In vivo effects of treatment with L-Grb2 in combination with anti-angiogenic therapy in an ovarian tumor model,” by Lara, et al. which reported that adaptor proteins such as growth factor … Read more